Ledger.Open graph →
SEC Form D · filed March 3, 2023

Akava Therapeutics Inc

Offering
$10.0M
Sold
—
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
WINNETKA, IL
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (7)

Richard Silverman · Winnetka, ILExec · DirectorPhilip Silverman · Winnetka, ILExec · DirectorWilliam W. Soucy · South Windsor, CTExec · DirectorBrendan Macmillan · Winnetka, ILDirectorSebastian Barriga · Cambridge, MAExec · DirectorBrendan Macmillan · Winnetka, ILDirectorPhilip Silverman · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗